610
T. LIU ET AL.
of dicyclohexyl phosphite (492 mg, 2 mmol) and TCT (295 mg, 1.8 mmol) in 5 mL
acetonitrile was added DMSO (780 mg, 10 mmol). The mixture was stirred at 80 ◦C and
monitored by TLC until completion (1 h). Then, the reaction mixture was added to ethyl
acetate (30 mL), washed with water (3 × 10 mL). The organic layers were combined and
concentrated in vacuum to give the crude product that was purified by silica gel column
chromatography to afford O,O-dicyclohexyl S-methyl phosphorothioate (395 mg, yield
68% based on the amount of the phosphite used). Oil. IR: 2937, 2859, 1546, 1344, 1251,
1
985, 889, 673. H NMR (CDCl3): δ = 4.35 (m, 2H), 2.29 (d, J = 12 Hz, 3H), 1.98 (m,
4H), 1.75 (m, 4H), 1.55 (m, 6H), 1.33 (m, 6H). 13C NMR (CDCl3): δ = 77.2, 33.4, 25.1,
23.6, 12.7. 31P NMR (CDCl3): δ = 25.9. MS (ESI) m/z (%) 607 [2M + Na]+ (100). HRMS
(ESI): m/z [M + Na]+ calcd for C13H25O3PSNa: 315.1154; found: 315.1159.
O,O-Bis(2-isopropyl-5-methylcyclohexyl) S-methyl phosphorothioate (Table 1,
◦
◦
1
Entry 5): mp 56 C–58 C. IR: 2933, 2929, 1637, 1511, 1329, 1251, 950, 823, 804. H
NMR (CDCl3): δ = 4.25 (m, 2H), 2.32 (d, J = 12 Hz, 3H), 2.18 (m, 2H), 1.76–0.78 (m,
32H). 13C NMR (CDCl3): δ = 79.3, 48.6, 42.7, 34.0, 31.6, 25.4, 22.8, 21.9, 21.1, 15.8, 12.6.
31P NMR (CDCl3): δ = 25.9. MS (ESI) m/z (%) 831 [2M + Na]+ (100). HRMS (ESI): m/z
[M + Na]+ calcd. for C21H41O3PSNa: 427.2412; found: 427.2413.
O,O-Bis(3β-acetoxy-androst-5-en-17β-yl) S-methyl phosphorothioate (Table 1,
Entry 6): mp 230 ◦C–233 ◦C. IR: 3034, 2929, 2830, 1732, 1630, 1472, 1442, 1371, 1259,
1
1152, 1011, 936, 883, 800, 633. H NMR (CDCl3): δ = 5.39 (s, 2H), 4.62 (m, 2H), 4.31
(m, 2H), 2.33 (d, J = 8 Hz, 3H), 2.05 (s, 6H), 1.05 (s, 6H), 0.84 (s, 6H). 13C NMR (CDCl3):
δ = 170.4, 139.8, 122.1, 86.5, 73.8, 42.9, 36.5, 31.8, 31.4, 29.7, 28.5, 27.7, 23.4, 21.4, 20.5,
19.3, 12.7, 11.6. 31P NMR (CDCl3): δ = 27.3. MS (ESI) m/z (%) 779 [M + Na]+ (100).
HRMS (ESI): m/z [M + Na]+ calcd for C43H65O7PSNa: 779.4086; found: 779.4077.
O,O-Bis(3β-acetoxy-5α-androstan-17β-yl) S-methyl phosphorothioate (Table 1,
Entry 7): mp 222 ◦C–226 ◦C. IR: 2929, 2880, 1731, 1472, 1443, 1371, 1341, 1259, 1152,
1
1131, 1011, 935, 883, 633. H NMR (CDCl3): δ = 4.70 (m, 2H), 4.31 (m, 2H), 2.28 (d,
J = 8 Hz, 3H), 2.05 (s, 6H), 0.84 (s, 6H), 0.81 (s, 6H). 13C NMR (CDCl3): δ = 170.6, 86.6,
73.6, 54.2, 50.1, 44.6, 43.2, 36.9, 35.5, 33.9, 31.4, 27.4, 23.4, 21.5, 20.5, 12.2, 11.8. 31P
NMR (CDCl3): δ = 27.2. MS (ESI) m/z (%) 1544 [2M + Na]+ (100). HRMS (ESI): m/z
[M + Na]+ calcd for C43H69O7PSNa: 783.4399; found: 783.4390.
O,O-Dimethyl S-methyl-d3 phosphorothioate (Table 3, Entry 1): In the reaction
of TCT-activated DMSO-d6, DMSO-d6 was used to replace DMSO. Oil. IR: 2940, 2856,
1546, 1384, 1250, 988, 886, 655. 1H NMR (DMSO-d6): δ = 3.72 (d, J = 12 Hz, 6H). 13
C
NMR (DMSO-d6): δ = 54.1. 31P NMR (CDCl3): δ = 32.4. MS (ESI) m/z (%) 341 [2M +
Na]+ (100). HRMS (ESI): m/z [M + Na]+ calcd. for C3H6D3O3PSNa: 182.0093; found:
182.0096.
O,O-Dicyclohexyl S-methyl-d3 phosphorothioate (Table 3, Entry 2): Oil. IR: 2935,
2855, 1548, 1346, 1252, 987, 886, 677. 1H NMR (CDCl3): δ = 4.49 (m, 2H), 1.99 (m, 4H),
1.77 (m, 4H), 1.57 (m, 6H), 1.35 (m, 6H). 13C NMR (CDCl3): δ = 77.2, 33.4, 25.1, 23.6.
31P NMR (CDCl3): δ = 25.9. MS (ESI) m/z (%) 613 [2M + Na]+ (100). HRMS (ESI): m/z
[M + Na]+ calcd. for C13H22D3O3PSNa: 318.1345; found: 318.1341.
O,O-Bis(3β-acetoxy-androst-5-en-17β-yl)
S-methyl-d3
phosphorothioate
◦
(Table 3, entry 3): mp 225◦C–229 C. IR: 3030, 2986, 2896, 1732, 1442, 1401, 1373,
1345, 1252, 1024, 934, 874, 800, 633. 1H NMR (CDCl3): δ = 5.40 (s, 2H), 4.62 (m, 2H),
4.32 (m, 2H), 2.05 (s, 6H), 1.05 (s, 6H), 0.84 (s, 6H). 13C NMR (CDCl3): δ = 170.5, 139.8,
122.1, 86.6, 73.8, 50.4, 49.9, 42.9, 38.1, 36.6, 31.8, 31.3, 28.8, 27.7, 23.4, 21.4, 20.5, 19.3.